CHOOSE YOUR DESIRED LEVEL OF ACCESS
Join the next era of global innovation and dealmaking in China.
ChinaBio® Partnering Forum 2026 connects innovative life science companies from China with global partners, investors, and industry leaders. Whether attending in-person in Shanghai April 28–29, 2026 or virtually May 6–7, our flexible registration options ensure you can engage effectively with this vibrant market.
Choose the registration path that fits your goals.
R&D / Academic / Gov
R&D Qualifying Criteria
Biotech, Pharma, Drug Delivery, Diagnostic, Medical Device companies actively developing products, and platform companies supporting drug discovery and development for which they own the IP.
Academic
Institutes, academic spinoffs, tech transfer officers and other academic researchers and innovators.
Government
Government departments and organizations, and registered non-profit organizations.
Service Provider
This pass is for companies that provide services to the life sciences industry. Please see criteria below:
Companies doing business as a CRO, CMO, CDMO or providing solutions and/or professional services and consultants, must register under this rate.
Sponsor or Exhibit
Enrich your participation and maximize your success with an exhibit space on-site or event sponsorship.
Presenting company
Showcase your company in an in-person presentation during ChinaBio® Partnering Forum, April 28–29, 2026 or digital presentation that will be available to all registered attendees up to three weeks before the event to engage with and request one-to-one meetings.
Presentation Tracks:
- Biotech Companies
- Midsize Pharma Companies
- Next Generation Biotech Companies
- Academic Innovators
Startup Spotlight
Startup companies are invited to apply to pitch their company at the Startup Spotlight at ChinaBio® Partnering Forum. This exciting competition offers innovative entrepreneurs an affordable opportunity to engage with top-tier investors and other important players in the biotech industry to take their business to the next level.
Selected companies will have the opportunity to make a 6-minute pitch and participate in a live feedback session with a jury of leading investors, pharma dealmakers, and biotech business key opinion leaders who will evaluate the pitches and select the winner onsite.
Applications can be submitted by companies that meet the following eligibility criteria:
- Company created in the past three years, or innovation incubated within a company for a maximum of three years
- Developing new therapeutic solutions, technology and digital platforms
- Aggregate funding of 10 million USD or less
- Company with less than 25 employees
Digital Pass Only
The digital pass grants you access to the ChinaBio® Partnering Forum digital days from May 6–7, 2026. Besides virtual one-to-one meetings, you will have on-demand access to an extensive library of event content. This includes program sessions, presenting companies and sponsor and showcase companies.